| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 06/26/2008 | WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives |
| 06/26/2008 | WO2007118149A3 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers |
| 06/26/2008 | US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease |
| 06/26/2008 | US20080153890 Phosphinic Amino Acid Compounds |
| 06/26/2008 | US20080153846 Especially 1-(5-((R)-2-Amino-1-phenylpropan-2-yl)-1,3,4-oxadiazol-2-yl)methyl)-4-butylpiperazine-2,3-dione or derivatives; amyloid precursor protein-cleaving enzyme |
| 06/26/2008 | US20080153838 Compounds Having Tie2 (Tek) Activity |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153834 Certain Substituted Amides, Method of Making, and Method of Use Thereof |
| 06/26/2008 | US20080153823 a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy |
| 06/26/2008 | US20080153821 Nitrogen-containing 5-membered ring compound |
| 06/26/2008 | US20080153816 Indole Compounds, Method of Preparing Them and Uses Thereof |
| 06/26/2008 | US20080153815 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 06/26/2008 | US20080153812 Novel compounds |
| 06/26/2008 | US20080153801 Benzoxazepine compounds, their production and use |
| 06/26/2008 | DE102007023102A1 Bisoxime als Fungizide Bisoximes as fungicides |
| 06/26/2008 | DE102006060598A1 New tetrahydrobenzoisoxazole compounds are mitotic motor protein Eg5 modulators useful to treat and prevent cancer, and to treat e.g. monocyte leukemia, glioblastoma, colon carcinoma, myelotic leukemia and lymphatic leukemia |
| 06/26/2008 | CA2673841A1 Prophylactic or therapeutic agent for alopecia |
| 06/26/2008 | CA2673468A1 Indole derivatives as s1p1 receptor agonists |
| 06/26/2008 | CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | CA2673177A1 Modulators of cb1 receptors |
| 06/26/2008 | CA2673119A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors |
| 06/26/2008 | CA2672776A1 2-substituted 5-membered heterocycles as scd inhibitors |
| 06/26/2008 | CA2672661A1 Process for the preparation of piperazinyl and diazepanyl benzamide derivatives |
| 06/26/2008 | CA2672521A1 Pyrazole derivatives as protein kinase inhibitors |
| 06/26/2008 | CA2672286A1 Organic compounds |
| 06/26/2008 | CA2672271A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 06/25/2008 | EP1935892A1 Glycyrrhetinic acid-30-amide derivatives and the uses thereof |
| 06/25/2008 | EP1935890A1 2-heteroaryl-substituted indole derivative |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935420A1 2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors |
| 06/25/2008 | EP1934210A1 Diazine azole derivatives, their manufacture and use as pharmaceutical agents |
| 06/25/2008 | EP1934209A1 5- (phenylisoxazolylethoxy) -triazol- 3 -yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders |
| 06/25/2008 | EP1934208A1 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
| 06/25/2008 | EP1934207A1 Substituted 4-phenyl piperidines for use as renin inhibitors |
| 06/25/2008 | EP1934206A1 Phenyl- and pyridyl-i, 2 , 4 -oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 06/25/2008 | EP1934205A1 Substituted quinolines as inhibitors of leukotriene biosynthesis |
| 06/25/2008 | EP1934204A2 Process for preparation of aprepitant |
| 06/25/2008 | EP1934203A2 Alpha2c adrenoreceptor agonists |
| 06/25/2008 | EP1934192A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 06/25/2008 | EP1934182A1 N-substituted pyridinone or pyrimidinone compounds useful as soluble epoxide hydrolase inhibitors |
| 06/25/2008 | EP1934174A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 06/25/2008 | EP1933834A1 Benzoxazoles useful in the treatment of inflammation |
| 06/25/2008 | EP1675850B1 Quinoline compounds and their uses |
| 06/25/2008 | EP1606266A4 Chemical compounds |
| 06/25/2008 | EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
| 06/25/2008 | CN101208335A Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 06/25/2008 | CN101208334A Novel cyclic amines |
| 06/25/2008 | CN101208327A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/25/2008 | CN101208302A Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/25/2008 | CN101208094A Pharmacokinetically improved compounds |
| 06/25/2008 | CN100396680C Vla-4 inhibitors |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396677C 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 06/25/2008 | CN100396672C N-alkynyl-2-heteroaryloxyalkylamides for use as fungicides |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390898 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 06/24/2008 | US7390826 Inhibitors of animal cell motility and growth |
| 06/24/2008 | US7390825 Process for the preparation of oxazolidinones and method of use thereof |
| 06/24/2008 | US7390822 Delta-2 opioid receptor agonists; protecting cardiac and cerebral organs |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390811 Respiratory syncytial virus replication inhibitors |
| 06/24/2008 | US7390810 Pyrazole-amine compounds useful as kinase inhibitors |
| 06/24/2008 | US7390805 Tyrosine kinase inhibitors; antiproliferative agents; antitumor agents |
| 06/24/2008 | US7390804 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition |
| 06/24/2008 | US7390799 N-acylsulfonamides; BCL-X1 protein inhibitors; anticarcinogenic agents; bladder cancer; N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide |
| 06/19/2008 | WO2008073519A1 Process for preparing substituted diaminopyrimidine oximes |
| 06/19/2008 | WO2008073480A1 Compounds and compositions as kinase inhibitors |
| 06/19/2008 | WO2008073306A1 Organic compounds |
| 06/19/2008 | WO2008072850A1 Triazine derivatives having inhibitory activity against acetyl-coa carboxylase |
| 06/19/2008 | WO2008072849A1 Method of preparing docetaxel and intermediates used therein |
| 06/19/2008 | WO2008072784A1 Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents |
| 06/19/2008 | WO2008072743A1 Method for producing anthranilamide compound by using novel pyrazole compound as intermediate |
| 06/19/2008 | WO2008072658A1 2-phenylnicotinic acid derivative |
| 06/19/2008 | WO2008071451A1 Dihydropyridine derivatives useful as protein kinase inhibitors |
| 06/19/2008 | WO2008071405A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides |
| 06/19/2008 | WO2008071400A1 Process for the preparation of valsartan and intermediate products |
| 06/19/2008 | WO2008071311A1 Sulfonyl-phenyl-2h-[1,2,4]oxodiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals |
| 06/19/2008 | WO2008051873A3 Phenylurea compounds as soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 06/19/2008 | WO2008010022A3 A process for preparation of racemic nebivolol |
| 06/19/2008 | WO2006078621A9 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 06/19/2008 | US20080146797 Process for synthesizing heterocyclic compounds |
| 06/19/2008 | US20080146631 Peroxisome proliferator activated receptor modulators; diabetes mellitus; side effects reduction; 2-Methyl-2-{4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]phenoxy}propionic acid; Syndrome X, Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis |
| 06/19/2008 | US20080146627 Thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives, e.g., butyl 2-(4-[1,1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate inhibit lipidic peroxidation and monoamine oxidase and modulate sodium channels and are used for treating neurodegenerative disorders or pain. |
| 06/19/2008 | US20080146573 Preparation and utility of substituted oxzolidinones |
| 06/19/2008 | US20080146572 N-sulfonylurea apoptosis promoters |
| 06/19/2008 | US20080146571 potent deoxycytidine kinase inhibitors; O-linked pyrimidin-4-amine-based compounds |
| 06/19/2008 | US20080146569 Nicotinamide Derivatives |
| 06/19/2008 | US20080146568 Spiro-piperidine derivatives |
| 06/19/2008 | US20080146565 JNK modulators |
| 06/19/2008 | US20080146561 Certain chemical entities, compositions and methods |
| 06/19/2008 | US20080146560 1-[4-(4-amino-5-oxo-5H-pyrido[2,3-d]pyrimidin-8-yl)phenyl]-3-(5-tert-butylisoxazol-3-yl)urea; treatment of tyrosine kinase-induced diseases and conditions, such as angiogenesis, cancer, tumour formation, growth and propagation, arteriosclerosis, ocular diseases, such as age-induced macular degeneration |
| 06/19/2008 | US20080146559 useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; useful in treating obesity |
| 06/19/2008 | US20080146558 4,5,6,7-Tetrahydro-Thieno [3,2-C] Pyridine Derivatives |
| 06/19/2008 | US20080146550 HETEROARYLACETAMIDE INHIBITORS OF FACTOR Xa |
| 06/19/2008 | US20080146545 Macrocyclic compounds useful as inhibitors of kinases and HSP90 |
| 06/19/2008 | US20080146539 New carboxylic acid amides, the preparation thereof and their use as medicaments |